SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of InVivo Therapeutics Holding Corp. (NVIV)

Montag, 31.07.2017 18:50 von PR Newswire - Aufrufe: 421

PR Newswire

NEW YORK, July 31, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of InVivo Therapeutics Holding Corp. ("InVivo" or the "Company") (NASDAQ: NVIV). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/nviv.

Bronstein, Gewirtz & Grossman, LLC

The investigation concerns whether InVivo and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On July 31, 2017, InVivo revealed that after a third patient death, it had stopped a trial of its Neuro-Spinal Scaffold, a spinal cord injury treatment and advised investors that the it had decided to stop the trial while it discusses with the U.S. Food and Drug Administration whether to change the trial's enrollment criteria. Following this news, InVivo stock dropped as much as $0.80 per share, or 32.65%, during intraday trading on July 31, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of InVivo, you can assist this investigation by visiting the firm's site: www.bgandg.com/nviv. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-invivo-therapeutics-holding-corp-nviv-300496635.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

Mehr Nachrichten kostenlos abonnieren
E-Mail-Adresse
Ich möchte Benachrichtigungen von ARIVA.DE erhalten.
Ja, ich habe die Datenschutzhinweise gelesen und akzeptiert (Pflichtfeld).

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.

Kurse